Abstract
Large bowel obstruction is a mechanical blockage of the colon causing abdominal distention and decreased bowel function. It is defined as 6 cm of colonic dilation or 9 cm of cecal dilation. Ogilvie syndrome, or colonic pseudo-obstruction, is a large bowel obstruction without an anatomic lesion, while stercoral colitis is dilation from impacted stool causing bowel wall inflammation. Although mechanical obstructions and volvulus generally require surgical management, pseudo-obstruction without 12 cm or more of dilation, peritonitis, or severe pain can often be managed conservatively with aggressive bowel regimens. Neostigmine, a cholinesterase inhibitor, is shown to be up to 90% effective in Ogilvie syndrome cases when conservative therapies fail. When pharmacotherapies are unsuccessful, colonoscopic decompression or surgery may be needed.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
FormalPara Pearls and Pitfalls-
6 cm of dilation in the large intestine or 9 cm in the cecum is considered pathologic.
-
Common mechanical causes of large bowel obstruction (LBO) include neoplasm, sigmoid volvulus, and diverticular complications such as stricture or abscess.
-
LBO can be associated with electrolyte abnormalities including hypomagnesemia, hypokalemia, and hypercalcemia. It is also associated with hypothyroidism.
-
Iatrogenic pharmacologic causes include opiates, anticholinergics, antihistamines, antipsychotics, and tricyclic antidepressants.
-
Neostigmine is reserved for colonic pseudo-obstruction with either more than 12 cm of dilation or failure of conservative management.
-
Failure of pharmacologic therapies for colonic pseudo-obstruction may require colonoscopy or surgery for decompression.
Large Bowel Obstruction, Ogilvie Syndrome, and Stercoral Colitis: When Is Dilatation Pathologic?
Large bowel obstruction (LBO) is a condition characterized by abdominal distention and failure to pass flatus due to a blockage in the large intestine. Abdominal pain, nausea, vomiting, and constipation are commonly described, though the absence of any of these symptoms does not rule out the diagnosis. In one case series, 41% of patients with large bowel obstruction had diarrhea [1]. More than half LBOs are related to cancer, but infection, hernia, strictures, and volvulus are other common causes [2]. When no structural abnormality can be found, LBO is termed Ogilvie syndrome or colonic pseudo-obstruction. This condition has multiple etiologies: electrolyte abnormalities, endocrine disorders, neurologic disorders, inflammatory bowel disease such as ulcerative colitis, medications that slow gut motility such as opioids, and anticholinergic medications [3, 4]. As these obstructions progress, increased pressure on the bowel wall may cause edema and inflammation. This condition is known as stercoral colitis, defined as 3 mm or more of bowel wall edema. Stercoral colitis rarely causes ischemia, and perforation occurs ~0.5% of the time [5]. The routine use of antibiotics is not indicated in these conditions; however, when complications develop, antibiotic use and surgical consultation for source control may be warranted.
Dilation of ≥6 cm in the large bowel or ≥ 9 cm in the cecum defines LBO [6]. When colonic dilation reaches ≥12 cm, risk of colonic perforation significantly increases. Computed tomography is the most useful imaging study, as it may identify the transition point, potential causes, and evidence of perforation. Intravenous contrast aides in identifying bowel wall involvement and/or inflammation [7].
How Are These Conditions Managed?
The treatment of LBO is determined by the etiology. Mechanical causes such as neoplasm or mass generally require surgical intervention. However, cases of pseudo- or functional obstruction often respond well to conservative management, consisting of bowel rest, nasogastric and/or rectal tube decompression, removal of potential causative agents, disimpaction, and tap water enemas [1]. As these conditions generally do not resolve quickly, patients are usually kept in the hospital in either observation or full admission status.
If conservative treatment of Ogilvie syndrome does not resolve the obstruction within 48 h or if there is severe dilation (greater than 12 cm), neostigmine is indicated. Neostigmine is an acetylcholinesterase inhibitor, which increases acetylcholine levels in the gut and thus stimulates gastrointestinal motility. Two milligrams are administered IV over 5 min, and the patient must be maintained on cardiac monitoring during and for 30 min after delivery [8]. Since neostigmine can cause bradycardia, atropine should be available; however, dosing glycopyrrolate with the neostigmine may reduce this side effect [9]. It is important to avoid neostigmine for structural obstructions, as it may cause perforation. When used appropriately, neostigmine is up to 90% effective. After successful treatment, adding propylene glycol helps prevent recurrence [10, 11]. Colonoscopy with placement of a decompression tube or surgery is sometimes needed if conservative management is not successful or if there is recurrence [12].
Perforation of the colon associated with LBO, Ogilvie syndrome, or stercoral colitis requires surgical management. Even with treatment, mortality rates have been reported as high as 53%, with long segments of dilated bowel (>40 cm) associated with higher mortality. Early diagnosis is paramount [7].
Suggested Resources
-
Chong JCF. Megacolon. 2017 [cited 2017 Aug 31]. Available from: http://www.emnote.org/emnotes/megacolon
-
Maloney N, Vargas HD. Acute intestinal pseudo-obstruction (Ogilvie’s syndrome). Clin Colon Rectal Surg. 2005;18(2):96–101.
-
Nickson C. Illeus [internet]. 2017 [cited 2017 Aug 31]. Available from https://lifeinthefastlane.com/ccc/ileus/
-
Thurson M, Jones J. Large bowel obstruction [internet]. 2017 [cited 2017 Aug 31]. Available from: https://radiopaedia.org/articles/large-bowel-obstruction
References
Vanek VW, Al-Salti M. Acute pseudo-obstruction of the colon (Ogilvie’s syndrome). An analysis of 400 cases. Dis Colon Rectum. 1986;29(3):203–10.
Ballantyne GH. Review of sigmoid volvulus. Clinical patterns and pathogenesis. Dis Colon Rectum. 1982;25(8):823–30.
Shera IA, Vyas A, Bhat MS, Yousuf Q. Unusual case of Hashimoto’s encephalopathy and pseudo-obstruction in a patient with undiagnosed hypothyroidism: a case report. J Med Case Rep. 2014;8:296.
Weinstock LB, Chang AC. Methylnaltrexone for treatment of acute colonic pseudo-obstruction. J Clin Gastroenterol. 2011;45(10):883.
Ünal E, Onur MR, Balcı S, Görmez A, Akpinar E, Boge M. Stercoral colitis: diagnostic value of CT findings. Diagn Interv Radiol. 2017 Jan;23(1):5–9.
Jaffe T, Thompson WM. Large-bowel obstruction in the adult: classic radiographic and CT findings, etiology, and mimics. Radiology. 2015;275(3):651–63.
Khurana B, Ledbetter S, McTavish J, Wiesner W, Rose PR. Bowel obstruction revealed by multidetector CT. Am J Roentgenol. 2002;178:1139–44.
Saunders MD, Kimmey MB. Systematic review: acute colonic pseudo-obstruction. Aliment Pharmacol Ther. 2005;22(10):917.
Korsten MA, Rosman AS, Ng A, Cavusoglu E, Spungen AM, Radulovic M, Wecht J, Bauman WA. Infusion of neostigmine-glycopyrrolate for bowel evacuation in persons with spinal cord injury. Am J Gastroenterol. 2005;100(7):1560.
Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med. 1999;341(3):137.
Sgouros SN, Vlachogiannakos J, Vassiliadis K, Bergele C, Stefanidis G, Nastos H, Avgerinos A, Mantides A. Effect of polyethylene glycol electrolyte balanced solution on patients with acute colonic pseudo obstruction after resolution of colonic dilation: a prospective, randomised, placebo controlled trial. Gut. 2006;55(5):638.
Acute CM. Colonic pseudo-obstruction (Ogilvie’s syndrome) [internet]. 2017 [updated 2017 July 5; cited 2017 Aug 31]. Available from: https://www.uptodate.com/contents/acute-colonic-pseudo-obstruction-ogilvies-syndrome
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pasichow, S.H., Jarman, A.F. (2019). Large Bowel Obstruction, Ogilvie Syndrome, and Stercoral Colitis: When Is Dilatation Pathologic? How Are These Conditions Managed?. In: Graham, A., Carlberg, D.J. (eds) Gastrointestinal Emergencies. Springer, Cham. https://doi.org/10.1007/978-3-319-98343-1_52
Download citation
DOI: https://doi.org/10.1007/978-3-319-98343-1_52
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98342-4
Online ISBN: 978-3-319-98343-1
eBook Packages: MedicineMedicine (R0)